GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Valuation Rank

Natco Pharma (NSE:NATCOPHARM) Valuation Rank


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Natco Pharma Valuation Rank Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (NSE:NATCOPHARM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Valuation Rank
Comparable Companies
BOM:543064 BOM:533573 BOM:543635 BOM:506820 BOM:540596 BOM:540222 BOM:500126 BOM:532482 BOM:532296 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524816:India
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Website
https://www.natcopharma.co.in
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.